个人简介
Roberto Furlan医生在IRCCS圣拉斐尔科学研究医院神经内科开展临床活动,在Massimo Filippi教授的指导下开展工作。
1991年从米兰大学医学专业毕业后,Furlan医生于2002年在伦敦Biologia Cellulare开放大学(c/o San Raffaele)获得博士学位。最后,2007年,他在米兰的Vita Salute San Raffaele获得神经学专业学位。
Furlan医生是临床神经免疫学系主任,实验神经病学研究所副所长。此外,Furlan医生还在圣拉斐尔生命健康大学大学作为合同讲师开展教学活动。
从临床角度来看,他主要在普通神经内科门诊开展活动。在临床和研究层面,他主要处理神经免疫学(例如多发性硬化)和精神(焦虑和抑郁)病理。
Furlan医生也是意大利神经免疫学协会主席。
他以作者或共同作者的身份在意大利国内外学术期刊上发表了多篇论文,也参与了书籍章节的编写,共计170多篇文章。H指数为55。定期作为发言人参加意大利国内外的行业会议。
出版物
最新出版物
Intravenous and intracerebroventricular injection of adult neurospheres induces clinical recovery in a chronic model of multiple sclerosis
Nature 2003; 422:688- 694
Neurosphere-derived multipotent precursors promote long-lasting neuroprotection by an immunomodulatory mechanism
Nature 2005 436:266-271
Secondary progressive MS: current knowledge and future challenges
Lancet Neurol. 2006 5:343-354
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis
Gene Ther. 2008 15: 504-515.
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis
J Neurosci. 2009 29:3442-52.
IL-17 and IFN- secreting FoxP3+ T cells infiltrate the target tissue in experimental autoimmunity
J Immunol. 2010 185:7467-73
Myeloid microvesicles are a marker and therapeutic target for neuroinflammation
Ann. Neurol. 2012 72:610-62
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica
Ann. Neurol. 2013 doi: 10.1002/ana.24079.
Increased M1/decreased M2 signature and signs of Th1/Th2 shift in chronic patients with bipolar disorder, but not in those with schizophrenia
Transl Psychiatry. 2014 Jul 1;4:e406. doi: 10.1038/tp.2014.46
Myeloid microvesicles in CSF are associated with myelin damage and neuronal loss in mild cognitive impairment and alzheimer disease
Ann. Neurol. 2014 doi: 10.1002/ana.24235.
Phagocytes-targeted extracellular vesicles containing IL4 inhibit neuroinflammation in a mouse model of multiple sclerosis
Mol. Ther. 2018 26:2107-2118. doi: 10.1016/j.ymthe.2018.06.024.
Serum neurofilaments increase at PML onset in natalizumab-treated MS patients
Ann Neurol. 2019 85:606-610. doi: 10.1002/ana.25437